Evidence map›Paper›PMID 36618798›Full record

ArticleAnnals of translational medicine2022

Interfering with

Shengcai Gu, Lei Shu, Lv Zhou, Yuxin Wang, Hanying Xue, Lan Jin, Zhiyu Xia, Xingliang Dai, Peng Gao, Hongwei Cheng

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Shengcai Gu *Department of Neurosurgery, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
Lei Shu *Department of Clinical Medicine, the First Clinical College of Anhui Medical University, Hefei, China.
Lv ZhouDepartment of Neurosurgery, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
Yuxin WangDepartment of Clinical Medicine, the First Clinical College of Anhui Medical University, Hefei, China.
Hanying XueDepartment of Clinical Medicine, the First Clinical College of Anhui Medical University, Hefei, China.
Lan JinDepartment of Clinical Medicine, the First Clinical College of Anhui Medical University, Hefei, China.
Zhiyu XiaDepartment of Clinical Medicine, the First Clinical College of Anhui Medical University, Hefei, China.
Xingliang DaiDepartment of Neurosurgery, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
Peng GaoDepartment of Neurosurgery, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Hongwei ChengDepartment of Neurosurgery, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
Anhui Medical University · CNFirst Affiliated Hospital of Anhui Medical University · CNNanjing University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: Sequencing data from glioma and normal tissues were downloaded from The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) databases, and the downloaded data were statistically analyzed using bioinformatics tools and the corresponding R package. The expression of Results: The expression of Conclusions:

Indexed as

apoptosisbioinformaticsCALCRLGliomaproliferation

Identifiers

PMID36618798
PMCPMC9816851
OpenAlexW4311511751

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.